Company Filing History:
Years Active: 2007
Title: Innovations of Andreas Christmann in Peptide Exposure Technology
Introduction
Andreas Christmann is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the method of exposing peptides and polypeptides on the surface of bacteria. His innovative approach has the potential to enhance various applications in research and medicine.
Latest Patents
Christmann holds a patent for a method that allows peptides or polypeptides to be exposed on the surface of gram-negative host bacteria using specific intimin-based anchor modules. The inventive method utilizes intimins with shortened carboxy terminals, which have been identified as particularly suitable anchor modules for passenger domains in the exterior cell membrane. According to the method, host bacteria are transformed using vectors that contain a fused nucleic acid sequence. This sequence consists of a segment coding for an intimin with a shortened carboxy terminal and a segment coding for the passenger peptide to be exposed. The invention enables a large number of passenger domains to be displayed on the bacterial cell surface without adversely affecting the bacteria's viability.
Career Highlights
Andreas Christmann is associated with Nascacell Technologies AG, where he continues to develop and refine his innovative methods. His work has garnered attention in the scientific community for its potential applications in various biotechnological fields.
Collaborations
Christmann has collaborated with notable colleagues such as Harald Kolmar and Alexander Wentzel, contributing to advancements in peptide technology and its applications.
Conclusion
Andreas Christmann's innovative methods in peptide exposure represent a significant advancement in biotechnology. His contributions have the potential to impact various fields, enhancing our understanding and application of peptides in research and medicine.